Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer

Journal of the National Cancer Institute

Volumn 103, Issue 8, 2011, Pages 645-661

  De Bacco, Francesca ^a   Luraghi, Paolo ^a   Medico, Enzo ^a   Reato, Gigliola ^a   Girolami, Flavia ^a   Perera, Timothy ^b   Gabriele, Pietro ^a   Comoglio, Paolo M ^a   Boccaccio, Carla ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2,6 DICHLOROBENZYLSULFONYL) 3 [3,5 DIMETHYL 4 [2 (1 PYRROLIDINYLMETHYL) 1 PYRROLIDINYLCARBONYL] 1H PYRROL 2 YLMETHYLENE] 1,3 DIHYDRO 2H INDOL 2 ONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN INHIBITOR; SCATTER FACTOR RECEPTOR; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; ATAXIA TELANGIECTASIA; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SIZE; CELL ASSAY; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CLONOGENIC ASSAY; DNA DAMAGE; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; IONIZING RADIATION; IRRADIATION; ONCOGENE; ONCOGENE MET; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; TUMOR CELL; WOUND HEALING; XENOGRAFT;

ANIMALS; APOPTOSIS; BLOTTING, NORTHERN; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; DNA DAMAGE; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; IN SITU NICK-END LABELING; INDOLES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM INVASIVENESS; NEOPLASMS; NF-KAPPA B; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-MET; RADIATION TOLERANCE; RADIATION, IONIZING; RADIATION-SENSITIZING AGENTS; RECEPTORS, GROWTH FACTOR; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SULFONES; TRANSCRIPTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 79955420135     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djr093     Document Type: Article

References (62)

1. Bernier J, Hall EJ, Giaccia A. Radiation oncology: a century of achievements. Nat Rev Cancer. 2004;4(9):737-747. (Pubitemid 39215072)
2. Suit HD. Local control and patient survival. Int J Radiat Oncol Biol Phys. 1992;23(3):653-660.
3. Kaplan HS, Murphy ED. The effect of local Roentgen irradiation on the biological behaviour of a transplantable mouse carcinoma. Increased frequency of pulmonary metastasis. J Natl Cancer Inst. 1949;9(5-6):407-413.
4. von Essen CF. Radiation enhancement of metastasis: a review. Clin Exp Metastasis. 1991;9(2):77-104.
5. Lovey J, Fazekas K, Ladanyi A, Nemeth G, Timar J. Low-dose irradiation and short-exposure suboptimal-dose paclitaxel adversely modulate metastatic potential of squamous carcinoma cells. Strahlenther Onkol. 2003;179(12):812-818. (Pubitemid 37509468)
6. Hegedus B, Zach J, Czirok A, Lovey J, Vicsek T. Irradiation and taxol treatment result in non-monotonous, dose-dependent changes in the motility of glioblastoma cells. J Neurooncol. 2004;67(1-2):147-157. (Pubitemid 38418263)
7. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444(7120):756-760. (Pubitemid 44949604)
8. Phillips TM, McBride WH, Pajonk F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst. 2006;98(24):1777-1785. (Pubitemid 46017929)
9. Baumann M, Krause M, Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer. 2008;8(7):545-554. (Pubitemid 351881850)
10. Barcellos-Hoff MH, Park C, Wright EG. Radiation and the microenvironment- tumorigenesis and therapy. Nat Rev Cancer. 2005;5(11):867-875.
11. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer. 2003;3(3):155-168. (Pubitemid 37328868)
12. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol. 2006;7(2):131-142. (Pubitemid 43278296)
13. Trusolino L, Comoglio PM. Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat Rev Cancer. 2002;2(4):289-300. (Pubitemid 37328782)
14. Boccaccio C, Comoglio PM. Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat Rev Cancer. 2006;6(8):637-645. (Pubitemid 44140861)
15. Comoglio PM, Giordano S, Trusolino L. Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat Rev Drug Discov. 2008;7(6):504-516. (Pubitemid 351767118)
16. Scheel C, Onder T, Karnoub A, Weinberg RA. Adaptation versus selection: the origins of metastatic behavior. Cancer Res. 2007;67(24):11476-11479.
17. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871-890.
18. Qian LW, Mizumoto K, Inadome N, et al. Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cancer cells. Int J Cancer. 2003;104(5):542-549. (Pubitemid 36337253)
19. Schweigerer L, Rave-Frank M, Schmidberger H, Hecht M. Sublethal irradiation promotes invasiveness of neuroblastoma cells. Biochem Biophys Res Commun. 2005;330(3):982-988. (Pubitemid 40462182)
20. Prat M, Narsimhan RP, Crepaldi T, Nicotra MR, Natali PG, Comoglio PM. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer. 1991;49(3):323-328.
21. Naldini L, Vigna E, Ferracini R, et al. The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylation. Mol Cell Biol. 1991;11(4):1793-1803. (Pubitemid 21895545)
22. Michieli P, Basilico C, Pennacchietti S, et al. Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists. Oncogene. 1999;18(37):5221-5231. (Pubitemid 29460658)
23. Gambarotta G, Boccaccio C, Giordano S, Ando M, Stella MC, Comoglio PM. Ets up-regulates MET transcription. Oncogene. 1996;13(9):1911-1917. (Pubitemid 26397450)
24. Franken NA, Rodermond HM, Stap J, Haveman J, van BC. Clonogenic assay of cells in vitro. Nat Protoc. 2006;1(5):2315-2319.
25. Boccaccio C, Gaudino G, Gambarotta G, Galimi F, Comoglio PM. Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF. J Biol Chem. 1994;269(17):12846-12851. (Pubitemid 24202082)
26. Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell. 2003;3(4):347-361. (Pubitemid 38340304)
27. Giordano S, Ponzetto C, Di Renzo MF, Cooper CS, Comoglio PM. Tyrosine kinase receptor indistinguishable from the c-met protein. Nature. 1989;339(6220):155-156. (Pubitemid 19122275)
28. Gu H, Neel BG. The 'gab' in signal transduction. Trends Cell Biol. 2003;13(3):122-130. (Pubitemid 36293784)
29. Christensen JG, Schreck R, Burrows J, et al. A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo. Cancer Res. 2003;63(21):7345-7355. (Pubitemid 37413476)
30. Schmidt-Ullrich RK, Contessa JN, Lammering G, Amorino G, Lin PS. ERBB receptor tyrosine kinases and cellular radiation responses. Oncogene. 2003;22(37):5855-5865. (Pubitemid 37176706)
31. Criswell T, Leskov K, Miyamoto S, Luo G, Boothman DA. Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation. Oncogene. 2003;22(37):5813-5827. (Pubitemid 37176702)
32. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell. 2008;132(3):344-362.
33. Gilmore TD. Rel/NF-kB Transcription Factors. 2008. www.NF-kB.org. Accessed January 11, 2011.
34. Nowak DE, Tian B, Jamaluddin M, et al. RelA Ser276 phosphorylation is required for activation of a subset of NF-kappaB-dependent genes by recruiting cyclin-dependent kinase 9/cyclin T1 complexes. Mol Cell Biol. 2008;28(11):3623-3638. (Pubitemid 351732900)
35. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004;18(18):2195-2224.
36. Dai JY, DeFrances MC, Zou C, Johnson CJ, Zarnegar R. The Met protooncogene is a transcriptional target of NF kappaB: implications for cell survival. J Cell Biochem. 2009;107(6):1222-1236.
37. Karin M, Cao Y, Greten FR, Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002;2(4):301-310. (Pubitemid 37328783)
38. Pouyssegur J, Mechta-Grigoriou F. Redox regulation of the hypoxia-inducible factor. Biol Chem. 2006;387(10-11):1337-1346. (Pubitemid 44691412)
39. Leach JK, Van TG, Lin PS, Schmidt-Ullrich R, Mikkelsen RB. Ionizing radiation-induced, mitochondria-dependent generation of reactive oxygen/nitrogen. Cancer Res. 2001;61(10):3894-3901. (Pubitemid 32720947)
40. Rius J, Guma M, Schachtrup C, et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature. 2008;453(7196):807-811. (Pubitemid 351793778)
41. The Wellcome Trust Sanger Institute. www.sanger.ac.uk. 2008. Accessed January 11, 2011.
42. Bullock AN, Fersht AR. Rescuing the function of mutant p53. Nat Rev Cancer. 2001;1(1):68-76. (Pubitemid 33741882)
43. Seol DW, Chen Q, Smith ML, Zarnegar R. Regulation of the c-met proto-oncogene promoter by p53. J Biol Chem. 1999;274(6):3565-3572. (Pubitemid 29077198)
44. Janssens S, Tschopp J. Signals from within: the DNA-damage-induced NF-kappaB response. Cell Death Differ. 2006;13(5):773-784.
45. Crescenzi E, Palumbo G, de BJ, Brady HJ. Ataxia telangiectasia mutated and p21CIP1 modulate cell survival of drug-induced senescent tumor cells: implications for chemotherapy. Clin Cancer Res. 2008;14(6):1877-1887. (Pubitemid 351469475)
46. Stoker M, Gherardi E, Perryman M, Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature. 1987;327(6119):239-242. (Pubitemid 17071053)
47. Albini A, Benelli R. The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation. Nat Protoc. 2007;2(3):504-511. (Pubitemid 47040014)
48. Trusolino L, Cavassa S, Angelini P, et al. HGF/scatter factor selectively promotes cell invasion by increasing integrin avidity. FASEB J. 2000;14(11):1629-1640. (Pubitemid 30636566)
49. Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell. 1991;67(5):901-908. (Pubitemid 121001504)
50. Montesano R, Soulie P, Eble JA, Carrozzino F. Tumour necrosis factor alpha confers an invasive, transformed phenotype on mammary epithelial cells. J Cell Sci. 2005;118(pt 15):3487-3500. (Pubitemid 41246102)
51. Bertotti A, Comoglio PM. Tyrosine kinase signal specificity: lessons from the HGF receptor. Trends Biochem Sci. 2003;28(10):527-533. (Pubitemid 38366278)
52. Perera T, Lavrijssen T, Janssens B. JNJ-38877605: a selective Met kinase inhibitor inducing regression of Met driven tumor models. Presented at the 99th AACR Annual Meeting; 2008 April 12-16; San Diego (CA): Abstract 4837.
53. Eder JP, Vande Woude GF, Boerner SA, LoRusso PM. Novel therapeutic inhibitors of the c-Met signaling pathway in cancer. Clin Cancer Res. 2009;15(7):2207-2214.
54. Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol. 2002;3(3):221-227.
55. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006;441(7092):431-436. (Pubitemid 44050137)
56. Ahmed KM, Li JJ. NF-kappa B-mediated adaptive resistance to ionizing radiation. Free Radic Biol Med. 2008;44(1):1-13. (Pubitemid 350138635)
57. Stone HB, Coleman CN, Anscher MS, McBride WH. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol. 2003;4(9):529-536. (Pubitemid 38351709)
58. Sonnenberg E, Meyer D, Weidner KM, Birchmeier C. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol. 1993;123(1):223-235. (Pubitemid 23284877)
59. Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol. 2008;9(5):453-461. (Pubitemid 351597795)
60. Lal B, Xia S, Abounader R, Laterra J. Targeting the c-Met pathway potentiates glioblastoma responses to gamma-radiation. Clin Cancer Res. 2005;11(12):4479-4486. (Pubitemid 40825638)
61. Vigna E, Pacchiana G, Mazzone M, et al. 'Active' cancer immunotherapy by anti-Met antibody gene transfer. Cancer Res. 2008;68(22):9176-9183.
62. Prise KM, O'Sullivan JM. Radiation-induced bystander signalling in cancer therapy. Nat Rev Cancer. 2009;9(5):351-360.